Nujarin Jongruja

Nujarin Jongruja

Auto-generated profile, based on publicly available information

Nujarin Jongruja

Department of Microbiology, Faculty of Science, King Mongkut’s University of Technology Thonburi (KMUTT), Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 July 2020 in Russian Journal of Bioorganic Chemistry
Verified
Journal Article
Closed access
PDF file
YAYa’U Sabo Ajingi
Ya’U Sabo Ajingi
NJNujarin Jongruja
Nujarin Jongruja
The swift killing kinetics is an attractive characteristics of wide-spectrum antimicrobial activity of peptides, which made them generate great attention as possible antitoxin pharmaceutics for commercial development. Regrettably, and regardless of the significant capability of these composites and the expanded research attempts that were performed to move these compounds to the health care units, the outcome has been finite. Primarily, this is attributed to hurdles associated with the peptides’ low targeting to pathogens and selectivity, exuberant toxicity to human cells, proneness to protease attack, pathogen resistance, and cost of production, poor chemical and physical stability of the peptides, reduced activity based on pH and salt sensitivity, pharmacodynamics and pharmacokinetic issues among others. Protein engineering via rational design and computer-based techniques, such as molecular docking and molecular dynamics simulations, for instance, through amino acid modifications and chemical synthesis, and synergistic effects, has proven to be useful for improving the therapeutic index and antibacterial activity of these artificially made peptides. In this review, we tried to search from the literature and previous scientific findings and researches, to highlight the contribution of modern-day peptide engineering and experimental techniques. In particular, we analyzed rational design, peptide engineering, peptide synthesis, recombinant peptide production, and synergistic effects; and how these methods modulate the peptide and protein functions. It also provides a comprehensive and straightforward overview of several studies towards addressing the issue of some of the limitations affecting these essential compounds that could be efficiently adopted and applied in future investigations.

2 March 2022 in Biocatalysis and Agricultural Biotechnology
Verified
Journal Article
Closed access
Ya'u Sabo AjingiYa'u Sabo Ajingi
Ya'u Sabo Ajingi
SRSudarat Rodpan
Sudarat Rodpan
JUJiddah Nafiu Usman
Jiddah Nafiu Usman
YKYuichi Koga
Yuichi Koga
NJNujarin Jongruja
Nujarin Jongruja

1 January 2021 in Food Technology and Biotechnology
Verified
Journal Article
Open access
TFTita Foophow
Tita Foophow
DSDuangjai Sittipol
Duangjai Sittipol
NRNeeranuch Rukying
Neeranuch Rukying
WPWeerachon Phoohinkong
Weerachon Phoohinkong
NJNujarin Jongruja
Nujarin Jongruja
Research background. Haloalkaline proteases are one of the most interesting types of commercial enzymes in various industries due to their high specific activity and stability under extreme conditions. Biochemical characterization of enzymes is an important requirement for determining their potential for application in industrial fields. Most of microbial proteases have been isolated from Bacillus spp. In this study, the purification and characterization of an extracellular haloprotease produced from Bacillus sp. KB111 strain, which was previously isolated from mangrove forest sediments, are investigated for industrial applications. Experimental approach. The whole genome of KB111 strain was identified by DNA sequencing. Its produced protease was purified by salting out and anion-exchange chromatography, characterized based on protease activity and stability using a peptide substrate, and identified by LC-MS/MS. Results and conclusions. The strain KB111 was identified as Bacillus licheniformis. The molecular mass of its extracellular protease, termed KB-SP, was estimated to be 70 kDa. The optimal pH and temperature for the activity of this protease were 7 and 50 °C, respectively, while the enzyme exhibited maximal activity in the broad salinity range of 2–4 M NaCl. It was fully stable at an alkaline pH range of 7–11 at 50 °C with a half-life of 90 min. Metal ions such as K+, Ca2+ and Mg2+ could enhance the enzyme activity. Therefore, this protease indicates a high potential for the applications in the food and feed industry, as well as the waste management since it can hydrolyse protein at high alkaline pH and salt concentrations. The amino acid profiles of the purified KB-SP determined by LC-MS/MS analysis showed high score matching with the peptidase S8 of B. licheniformis LMG 17339, corresponding to the mature domain of a minor extracellular protease (Vpr). Amino acid sequence alignment and 3D structure modelling of KB-SP showed a conserved catalytic domain, a protease-associated (PA) domain and a C-terminal domain. Novelty and scientific contribution. A novel extracellular haloprotease from B. licheniformis was purified, characterized and identified. The purified protease was identified as being a minor extracellular protease (Vpr) and this is the first report on the halotolerance of Vpr. This protease has the ability to work in harsh conditions, with a broad alkaline pH and salinity range. Therefore, it can be useful in various applications in industrial fields.

1 April 2022 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
Ya'u Sabo AjingiYa'u Sabo Ajingi
Ya'u Sabo Ajingi
NRNeeranuch Rukying
Neeranuch Rukying
Aiyada AroonsriAiyada Aroonsri
Aiyada Aroonsri
NJNujarin Jongruja
Nujarin Jongruja
Recombinant active peptides are utilized as diagnostic and biotherapeutics in various maladies and as bacterial growth inhibitors in the food industry. This consequently stimulated the need for recombinant peptides' production, which resulted in about 19 approved biotech peptides of 1-100 amino acids commercially available. While most peptides have been produced by chemical synthesis, the production of lengthy and complicated peptides comprising natural amino acids has been problematic with low quantity. Recombinant peptide production has become very vital, cost-effective, simple, environmentally friendly with satisfactory yields. Several reviews have focused on discussing expression systems, advantages, disadvantages, and alternatives strategies. Additionally, the information on the antimicrobial activities and other functions of multiple recombinant peptides is challenging to access and is scattered in literature apart from the food and drug administration (FDA) approved ones. From the reports that come to our knowledge, there is no existing review that offers substantial information on recombinant active peptides developed by researchers and their functions. This review provides an overview of some successfully produced recombinant active peptides of ≤100 amino acids by focusing on their antibacterial, antifungal, antiviral, anticancer, antioxidant, antimalarial, and immune-modulatory functions. It also elucidates their modes of expression that could be adopted and applied in future investigations. We expect that the knowledge available in this review would help researchers involved in recombinant active peptide development for therapeutic uses and other applications.

4 January 2023 in Biocatalysis and Agricultural Biotechnology
Verified
Journal Article
Closed access
NUNafiu Jiddah Usman
Nafiu Jiddah Usman
KRKanyarat Rodrid
Kanyarat Rodrid
Ya'u Sabo AjingiYa'u Sabo Ajingi
Ya'u Sabo Ajingi
NTNatthida Tuncharoen
Natthida Tuncharoen
KMKunlasatri Meegnoen
Kunlasatri Meegnoen
NJNujarin Jongruja
Nujarin Jongruja